Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vodafone Group Plc And GlaxoSmithKline plc Link On African Vaccines Programme-Reuters
Reuters reported that Vodafone Group Plc and drugmaker GlaxoSmithKline plc are joining forces on a novel project to increase childhood vaccination rates in Mozambique using text messaging. At the same time Vodafone has formed a strategic partnership with the non-profit GAVI Alliance to study how health ministries across sub-Saharan Africa can use mobile technology to improve their immunisation programmes. The move is the latest example of mobile phones being used to improve healthcare in Africa. Now widespread across the continent, mobile phones are already deployed in other schemes, including ones to check that people are taking HIV/AIDS drugs properly. The one-year pilot project in Mozambique, supported by the Save the Children charity, will register mothers on a ministry of health database, alert them to the availability of vaccinations and allow them to schedule appointments by text. The aim is to increase the proportion of children covered by vaccination by an additional 5% to 10%.
Latest Developments for GlaxoSmithKline PLC
- Elan Corporation PLC Strikes $1 Billion GlaxoSmithKline Plc Royalty Deal With Theravance Inc-Reuters
- FDA Approves Glaxosmithkline Plc's Breo Ellipta To Treat Lung Disease Jointly Developed With Theravance Inc-DJ
- Glaxosmithkline Plc Opts To Sell Off Lucozade And Ribena Drink Brands-Reuters
- Glaxosmithkline Plc Declares First Interim Dividend
Latest Key Developments in Pharmaceuticals
- Valeant Pharmaceuticals International Inc Near Deal To Acquire Bausch & Lomb From Warburg Pincus LLC-Reuters
- Valeant Pharmaceuticals International Inc Near Deal To Acquire Bausch & Lomb-Reuters
- Astec LifeSciences Ltd Recommends Dividend; Announces Appointment Of Statutory Auditors
- J B Chemicals and Pharmaceuticals Ltd Recommends Dividend
- Share this
- Link this
- Digg this


Follow Reuters